Oaktree Acquisition Corp.
III Life Sciences does not have significant operations.
The company focuses on effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities.
It intends to target companies in the biopharmaceutical, medical devices, diagnostics, and specialized healthcare services sectors in North America and Europe.
The company was incorporated in 2024 and is based in Los Angeles, California.
| Reported date | EPSChange YoY | EstimateSurprise |
|---|---|---|
| Nov 13, 25 | 0.08 Increased by +900.00% | - |
| Aug 12, 25 | 0.08 | - |
| May 14, 25 | 0.07 | - |
| Dec 31, 24 | 0.06 | - |
| Oct 4, 24 | -0.01 | - |
| Fiscal ending date | RevenueChange YoY | IncomeChange YoY | ProfitChange YoY |
|---|---|---|---|
| Sep 30, 25 | 0.00 Decreased by N/A% | 1.97 M Increased by +4.19 K% | Increased by +N/A% Decreased by N/A% |
| Jun 30, 25 | 0.00 - | 1.87 M - | Increased by +N/A% - |
| Mar 31, 25 | 0.00 - | 1.66 M - | Increased by +N/A% - |
| Dec 31, 24 | 0.00 - | 1.38 M - | Increased by +N/A% - |
| Sep 30, 24 | 0.00 - | -48.09 K - | Decreased by N/A% - |